Legal Opinion

Apotex, Inc. v. Daiichi Sankyo, Inc.

Court of Appeals for the Federal Circuit

Decided March 31, 2015No. 2014-1282, 2014-1291PublishedCited by 10 opinions

1Opinion of the Court

TARANTO, Circuit Judge.

Apotex, Inc. brought this action against Daiichi Sankyo Co., Ltd. and Daiichi Sank-yo, Inc. (collectively, Daiichi) to obtain a declaratory judgment that Apotex will not infringe a patent owned but disclaimed by Daiichi if Apotex manufactures or sells a generic drug bioequivalent to Daiichi’s Be-nicar®. Apotex cannot infringe the patent, because Daiichi has disclaimed it, but Apotex nevertheless claims a concrete interest in obtaining a judgment of non-infringement for its generic drug because such a judgment would enable Apotex to receive marketing approval from the…

2Cases cited47 opinions

  1. Lujan v. Defenders of WildlifeSupreme Court of the United States · 1992
  2. Warth v. SeldinSupreme Court of the United States · 1975
  3. Allen v. WrightSupreme Court of the United States · 1984
  4. Village of Arlington Heights v. Metropolitan Housing Development Corp.Supreme Court of the United States · 1977
  5. Simon v. Eastern Kentucky Welfare Rights OrganizationSupreme Court of the United States · 1976

42 more not listed; retrieve them via the Exa API.

3Cited by10 opinions

  1. Acorda Therapeutics Inc. v. Mylan Pharmaceuticals Inc.Court of Appeals for the Federal Circuit · 2016
  2. Sanofi-Aventis U.S., LLC v. Fresenius Kabi USA, LLCCourt of Appeals for the Federal Circuit · 2019
  3. Amerigen Pharmaceuticals v. Ucb Pharma GmbhCourt of Appeals for the Federal Circuit · 2019
  4. Shenyang Yuanda Aluminum Indus. Eng'g Co. v. United StatesCourt of Appeals for the Federal Circuit · 2019
  5. Limited v. Daiichi Sankyo, Inc.District Court, N.D. Illinois · 2016

5 more not listed; retrieve them via the Exa API.

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API